2024. Concomitant Eruptive Squamous Atypia and Bullous Drug Eruption Associated with Pembrolizumab. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), 2006–2010. DOI:https://doi.org/10.25251/skin.8.6.17.